1. /
  2. Commercialisation /
  3. Stellabody® technology
Commercialisation

Stellabody® technology

Burnet’s Stellabody® technology exploits a natural antibody behaviour to facilitate the formation of hexamers. This enhances the action of antibodies and related biologics.

Our Immune Therapies group is an internationally recognised laboratory in antibody immune function and has significant expertise to transform antibody assets into a potent and efficacious therapeutic for treating cancer, autoimmune disease and infection.

Stellabody Flyer Cover Thumbnail

About Stellabody®

This flyer contains information about Stellabody® technology’s on-target hexamerisation, our Immune Therapies group’s capabilities, and our fee-for-service work.

Stellabody® flyer [PDF 270 kB]
On this page